GLP-1 drugs like Ozempic may lose heart-protective benefits quickly after stopping, with cardiovascular risk rising fast, a new Washington University School of Medicine study finds.
NEWYou can now listen to Fox News articles!
People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided.
GLP-1 receptor agonists — such as semaglutide (Ozempic and Wegovy), an... [5416 chars]